An analysis published in Health Affairs outlines the benefits of structuring negotiations and standardizing fee-for-service payments independent of any specific reform proposals to control health care spending in 3 high-income countries.
An analysis published in Health Affairs outlines the benefits of structuring negotiations and standardizing fee-for-service payments independent of any specific reform proposals to control health care spending in 3 high-income countries.
“Although the US has the highest health care prices in the world, the specific mechanisms commonly used by other countries to set and update prices are often overlooked, with a tendency to favor strategies such as reducing the use of fee-for-service reimbursement,” authors wrote.
Studies have shown that prices in the United States are higher than in other countries not because the volume of service is greater, but because costs are higher due to private insurers’ insufficient leverage in the market and dramatic price variations in the private market.
In most countries with universal health care, physicians are paid on a fee-for-service basis, researchers explained, whereas in the United States, fee-for-service private practice and third-party payment are thought to weigh down the health care system with financial incentives. US policy makers instead support more focus on market competition, managed care, price transparency, and performance measurement.
To better understand how France, Germany, and Japan appear to achieve economic sustainability in a fee-for-service system, researchers focused on how the governments balance the needs of physicians, patients, and insurers. In the 3 countries, legal residents are covered under universal health insurance by multiple insurers operating within a national statutory pricing framework for provider fees. Competition occurs among health care providers, not insurers, and plan enrollment is determined by an individual’s occupation.
Investigators reviewed and translated fee schedules, payment policy descriptions, reports and policy documents. They also sought assistance from health policy experts to identify interviewees. A total of 37 individuals (14 in France, 11 in Germany, and 12 in Japan) were interviewed between 2016 and 2018.
“In the course of our interviews…we sought to understand the process for creating physician fee schedules and updates, learn about recent policy changes in physician payment, and identify the remaining challenges in the use of fee-for-service payment to physicians,” authors wrote.
Although Japan, Germany, and France all negotiate fees in the context of expenditure constraints, the countries have different institutional processes to address health care prices and volumes. Researchers found:
Overall, the 3 health systems focus on controlling prices in the context of fee-for-service medical practice and national expenditure constraints that do not result in withholding health care for the population, authors wrote.
In the United States, the myriad of payment arrangements inhibits unified approaches and creates a growing pressure to change and standardize fees. In the absence of universal coverage, authors argued that the United States should regulate how much discretion providers of health care services have in setting their own prices.
“The ways and means by which France, Germany, and Japan are ‘getting the price right’ should not be ignored by US policy makers concerned with universal health insurance or with the incremental extension of affordable health insurance coverage,” the researchers concluded.
Reference
Gusmano MK, Laugesen M, Rodwin VG, Brown LD. Getting the price right: how some countries control spending in a fee-for-service sysyem. Health Aff (Millwood). 2020;39(11):1867-1874. doi:10.1377/hlthaff.2019.01804
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Study Highlights Disparities in Access to In-Network Mental Health Care vs Medical Care
April 17th 2024While health plans often employ reimbursement rates as a tool to incentivize provider participation within their networks, study results showed reimbursement rates for office visits with medical/surgical clinicians were on average 22% higher than behavioral health clinicians.
Read More